A California-based company called Gritstone has developed a new coronavirus vaccine called “GRT-R910”. This vaccine, which has a similar structure to mRNA vaccines, provides protection against all variants by developing itself in the body. Experts think that the vaccine may be the definitive solution to end the epidemic.
While the world’s fight against the coronavirus epidemic continues, there has been a development that will be talked about a lot in the USA. A company called Gritstone, which has started to be supported by the US National Institute of Health, announced that it has developed a new coronavirus vaccine. The vaccine named “GRT-R910”, which uses a similar production technique of mRNA-based vaccines, draws attention with its protectiveness against all variants.
The COVID-19 vaccine produced by Gritstone develops on its own after being injected into the body. This provides immunity against possible coronavirus variants. The scientists behind the vaccine state that GRT-R910, which is more effective than mRNA vaccines at much lower doses, has also reduced the possibility of side effects thanks to this feature. According to experts, the new vaccine developed is a much more advanced version of the vaccines developed by companies such as Moderna or BioNTech.
Gritstone officials explained that the vaccine was administered to 20 people aged 60 and over and they are working to analyze the results, while company CEO Dr. Andrew Allen added, “It will make a much bigger contribution than an extra vaccine from the same vaccine brand.” said. Stating that the vaccine, which is also very affordable in terms of cost, does not need advanced systems, scientists state that GRT-R910 can be produced even in hospitals. Moreover, if the coronavirus ends and another virus outbreak occurs, a vaccine can be developed for the new epidemic with the technique of GRT-R910.
The vaccine, which excites the scientific world and is thought to be the definitive solution against the epidemic, still needs to be tested for a long time before it can be applied. However, considering that there will be no problems with the theoretical examinations, it seems that this process can be accelerated. Perhaps Gritstone’s COVID-19 vaccine will be a life saver for all epidemics from now on…
The Wall Street Journal announced that Apple has developed a new feature for its Health app. This feature, which includes some universities in the USA and a pharmaceutical company, will be able to analyze the user’s data and detect health problems such as depression, anxiety or anxiety disorder.
US-based technology giant Apple seems to be trying to develop a new feature for iPhones. According to a report in The Wall Street Journal, Apple wants to use this feature to detect and inform the user that iPhone owners are experiencing conditions such as depression, cognitive and anxiety disorders, or anxiety. So how will this happen?
The new feature Apple is working on includes analyzing an iPhone owner’s facial expressions, walking speed, how he speaks, heart and respiratory measurement values, and data on sleep duration and quality. In addition, the company wants to try to understand whether the user has a psychological problem by evaluating the typos and typing speeds of the users.
Apple developed the new feature, which it is working on to detect health problems of users, together with state universities in California and Los Angeles and the pharmaceutical company Biogen. In other words, there are important scientists of the USA behind the project. However, this feature, as you can imagine, led to a discussion that Apple would monitor user data. However, people familiar with the subject state that the new feature that Apple is working on will not send data to the servers, all operations will be performed by the iPhone, thus protecting user privacy and security.
The new feature that Apple is working on is codenamed “Seabreeze”. The company will test Seabreeze with an agreement with 3,000 users. The scope of the studies to be started this year is planned to be increased to 20 thousand people through Biogen next year. Sources providing information to The Wall Street Journal state that Jeff Williams, who is responsible for Apple’s Health application, is very enthusiastic about this feature, and that very passionate and enthusiastic statements were made at the meetings held at the company.